Use cases / External evidence

External validation data for medical AI

External validation data should be independent from model development and representative of the intended clinical setting. MedCorpora can scope hospital, scanner, protocol, temporal and population holdouts with frozen inclusion rules, reference-standard evidence and traceable analysis inputs.

Published 30 July 2026 · Reviewed 12 August 2026 · MedCorpora
IndependencePatient · site · time
MeasuresPerformance · calibration
RobustnessScanner · protocol · population
ProtocolPre-specified analysis
01

What the programme covers

External validation asks whether performance transfers beyond the development distribution. Independence must be defined explicitly; a random split from the same archive may be a test set but not convincing external evidence.

02

What a useful specification includes

A defensible request defines the clinical task, source evidence and acceptance criteria before patient-level data moves. The exact fields and thresholds depend on the intended model claim.

  • Target clinical setting and intended use
  • Independent hospitals, devices or time periods
  • Expected prevalence and case selection
  • Reference standard and blinding
  • Primary metrics and confidence intervals
  • Subgroups, calibration and failure analysis
03

Quality and validation controls

Validation controls preserve a frozen cohort and evaluation protocol. Label access, exclusions and repeated analyses are tracked so the reported result can be interpreted.

  • Source and patient independence
  • Protocol and analysis version control
  • Ground-truth quality and blinding
  • Prevalence and spectrum assessment
  • Subgroup sample size and uncertainty
04

Availability, rights and delivery

The programme can provide a controlled cohort and evidence package appropriate to the agreed validation design, without representing it as regulatory approval.

Public pages describe a sourcing and engineering capability, not guaranteed ready inventory. Each release remains subject to verified programme inventory, programme-specific authorization, privacy review, technical acceptance and buyer licence terms.

05

Questions, answered directly.

Is a held-out random split external validation?

Usually not if it comes from the same source and period as development. Externality should match the intended claim.

Can validation use another country or population?

Potentially, if inventory, authority and reference standards support the design.

Should calibration be evaluated?

Yes when predicted probabilities will inform decisions; discrimination alone may not show whether risks are well calibrated.

Does external validation guarantee deployment success?

No. It provides evidence for a defined setting and should be combined with workflow, safety and monitoring considerations.

Institutional engagement

Define the cohort.